REG - CVS Group plc - Exercise of Options, PDMR Dealing, EBT and TVR

CVSAnnouncement

09/10/2023 15:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231009:nRSI4555Pa&default-theme=true

RNS Number : 4555P  CVS Group plc  09 October 2023

Immediate release
 
                             9 October 2023

 

CVS Group Plc

("CVS", the "Company" or the "Group")

Exercise of Options, PDMR Dealing, EBT Share Purchase and Total Voting Rights

CVS, the UK listed veterinary group and a leading provider of veterinary
services, announces that on 6 October 2023, options over a total of 107,903
new Ordinary shares of 0.2 pence each (the "New shares") were exercised under
the CVS Group 2020 Long Term Incentive Plan ("LTIP 14"), at an exercise price
of 0.2 pence.

 

Richard Fairman, Chief Executive Officer, Ben Jacklin, Deputy CEO, and Robin
Alfonso, Chief Financial Officer, exercised options over 41,030, 24,618 and
13,540 Ordinary shares of 0.2p each in the Company ("Ordinary shares")
respectively.  The balance of the options was exercised by certain other
employees of the Company.

 

On 6 October 2023, the Company was notified by JTC Employer Solutions Trustee
Limited, the trustee of the CVS Group Employee Benefit Trust (the "EBT"), that
the EBT had purchased a total of 56,896 of the New shares from LTIP 14
option-holders at a volume-weighted average price of £16.17 per Ordinary
share.  This included the purchase of shares by the EBT from Richard Fairman,
Ben Jacklin and Robin Alfonso to meet the costs of exercise incurred by them
as PDMR option-holders, including personal taxation, as set out below:

 

Name
Number of shares sold to EBT                    Price

Richard Fairman
19,510
£16.17

Ben
Jacklin
11,706
£16.17

Robin
Alfonso
6,439
£16.17

 

 

The New shares purchased by the EBT are intended to be used to satisfy the
exercise of share options by employees.  The EBT is a discretionary trust for
the benefit of the Company's employees, including the Directors of the
Company.  The purchase of the New shares by the EBT has been funded from the
Company's existing cash reserves.  Following this transaction, a total of
57,280 Ordinary shares are held by the EBT, representing approximately 0.08%
of the Company's total voting rights.

 

Admission of the New shares, which rank pari passu in all respects with the
Company's existing Ordinary shares, has been satisfied by the Company's block
listing admitted to the London Stock Exchange on 15 May 2023.

 

Following the issue of the New shares, the Company has a total issued share
capital of 71,537,662 Ordinary shares each carrying one voting right.  The
Company holds no Ordinary shares in treasury. Therefore, following the issue
of the New shares, the total number of voting rights in the Company will be
71,537,662.  This figure may be used by shareholders as the denominator for
the calculations by which they will determine if they are required to notify
their interest in, or a change to their interest in, the Company under the
FCA's Disclosure Guidance and Transparency Rules.

 

 

Following their respective option exercises, their sales of a portion of the
New shares arising and admission of the New shares, the Executive Directors,
together with their respective spouses, hold a beneficial interest in the
following Ordinary shares in the Company:

 

Name
Number of shares           Percentage interest in the Company

Richard Fairman
77,501
0.108%

Ben
Jacklin
36,714
0.051%

Robin
Alfonso
19,252
0.027%

 

The notification below, made in accordance with the requirements of the UK
Market Abuse Regulation, provides further detail.

 

Contacts:

CVS Group
plc
via Camarco

Richard Fairman, CEO

Scott Morrison, Company Secretary

 

Peel Hunt LLP (Nominated Adviser &
Broker)
+44 (0)20 7418 8900

Adrian Trimmings / Michael Burke / Andrew Clark / Lalit Bose

 

   Berenberg (Joint
Broker)
+44 (0)20 3207 7800

Toby Flaux / Ben Wright / James Thompson / Milo Bonser

 

Camarco (Financial
PR)

Geoffrey
Pelham-Lane
                     +44 (0)7733 124 226

Ginny
Pulbrook
+44 (0)7961 315 138

 

Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         Richard Fairman

 2    Reason for the notification

 a)   Position/status                                              Chief Executive Officer

 b)   Initial notification /Amendment                              Initial Notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         CVS Group plc

 b)   LEI                                                          213800J41XDQ2NX48O05

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  Ordinary shares of 0.2 pence each

      Identification code

                                                                   GB00B2863827

 b)   Nature of the transaction                                    i)          Exercise of options under LTIP 14

                                                                   ii)          Sale of Ordinary shares arising from exercise

 c)   Price(s) and volume(s)

Price(s)                         Volume(s)

                                                                   i)    Exercise price of 0.2p     41,030

                                                                                                    19,510

                                                                   ii)    1616.5321p

 

 d)   Aggregated information                                       N/A

      - Aggregated volume

      - Price

 e)   Date of the transaction                                      6 October 2023

 f)   Place of the transaction                                     i)          Outside a trading venue

                                                                   ii)          London Stock Exchange, AIM.

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

N/A

 

 

 

e)

 

Date of the transaction

 

 

6 October 2023

f)

 

Place of the transaction

 

 

i)          Outside a trading venue

ii)          London Stock Exchange, AIM.

 

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         Ben Jacklin

 2    Reason for the notification

 a)   Position/status                                              Deputy CEO

 b)   Initial notification /Amendment                              Initial Notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         CVS Group plc

 b)   LEI                                                          213800J41XDQ2NX48O05

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  Ordinary shares of 0.2 pence each

      Identification code

                                                                   GB00B2863827

 b)   Nature of the transaction                                    i)          Exercise of options under LTIP 14

                                                                   ii)          Sale of Ordinary shares arising from exercise

 c)   Price(s) and volume(s)                                       Price(s)                         Volume(s)

                                                            i)    Exercise price of 0.2p     24,618

                                                                                                    11,706

                                                                   ii)    1616.5321p

 

 d)   Aggregated information                                       N/A

      - Aggregated volume

      - Price

 e)   Date of the transaction                                      6 October 2023

 f)   Place of the transaction                                     i)          Outside a trading venue

                                                                   ii)          London Stock Exchange, AIM.

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

N/A

 

 

 

e)

 

Date of the transaction

 

 

6 October 2023

f)

 

Place of the transaction

 

 

i)          Outside a trading venue

ii)          London Stock Exchange, AIM.

 

 

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         Robin Alfonso

 2    Reason for the notification

 a)   Position/status                                              Chief Financial Officer

 b)   Initial notification /Amendment                              Initial Notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         CVS Group plc

 b)   LEI                                                          213800J41XDQ2NX48O05

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  Ordinary shares of 0.2 pence each

      Identification code

                                                                   GB00B2863827

 b)   Nature of the transaction                                    i)          Exercise of options under LTIP 14

                                                                   ii)          Sale of Ordinary shares arising from exercise

 c)   Price(s) and volume(s)                                       Price(s)                         Volume(s)

                                                            i)    Exercise price of 0.2p     13,540

                                                                                                    6,439

                                                                   ii)    1616.5321p

 

 d)   Aggregated information                                       N/A

      - Aggregated volume

      - Price

 e)   Date of the transaction                                      6 October 2023

 f)   Place of the transaction                                     i)          Outside a trading venue

                                                                   ii)          London Stock Exchange, AIM.

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

N/A

 

 

 

e)

 

Date of the transaction

 

 

6 October 2023

f)

 

Place of the transaction

 

 

i)          Outside a trading venue

ii)          London Stock Exchange, AIM.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCEADENESLDFFA